Mecaplast SA

Mecaplast SA, based in Switzerland, specializes in plastic injection molding, offering a range of services including engineering, design, and logistics, tailored to various sectors such as medical and luxury goods. Founded in 1971, Mecaplast SA operates from its headquarters in Fribourg, Switzerland. The company focuses on plastic injection molding and has developed custom solutions for diverse industries. It has engaged in a recent acquisition by Schivo Medical, a portfolio company of MML Capital Ireland, on September 3, 2025, enhancing its business development capabilities.

Mecaplast Swiss specializes in plastic injection molding, providing comprehensive services that include engineering, design, tool and mold making, assembly, quality assurance, finishing, and logistics. The company focuses on developing custom solutions for specific client needs across various sectors, including medical, luxury goods, and composite materials. All products are produced in-house, with marketing and sales primarily directed at businesses in Europe and North America. Mecaplast Swiss generates revenue through direct B2B transactions, primarily with companies in the medical and luxury sectors.

Their pricing structure is based on custom quotes, encompassing design, production, and delivery. Key services include advanced 3D prototyping and sterilization processes critical for medical clients, supported by strong industry partnerships to ensure service excellence. Looking forward, Mecaplast plans to leverage the recent acquisition by Schivo Medical to enhance its business development strategies. Specific upcoming products are being designed, with an aim to expand into new markets by 2026.

The acquisition will facilitate investments in these growth initiatives, fostering further opportunities in the medical and luxury sectors.